HUVITZ CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,700 KRW | 0.00% |
|
+0.74% | -28.08% |
| 2023 | Huvitz Co., Ltd.(KOSDAQ:A065510) added to S&P Global BMI Index | CI |
| 2023 | Huvitz Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -28.08% | 110M | - | ||
| -19.42% | 18.12B | A | ||
| -41.90% | 2.87B | C+ | ||
| +19.36% | 1.9B | - | ||
| -1.05% | 1.65B | - | ||
| +33.96% | 1.34B | B+ | ||
| -16.83% | 957M | - | ||
| -21.96% | 896M | - | C- | |
| +7.07% | 841M | - | ||
| -26.98% | 612M | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
- Stock Market
- Equities
- A065510 Stock
- Ratings Huvitz Co., Ltd.
